21 results
8-K
EX-2.1
PFE
Pfizer Inc.
13 Mar 23
Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion
8:29am
10-K
2020 FY
EX-2.8
PFE
Pfizer Inc.
Annual report
25 Feb 21
1:59pm
10-Q
2020 Q3
EX-2.1
PFE
Pfizer Inc.
Quarterly report
5 Nov 20
4:57pm
8-K
EX-2.2
PFE
Pfizer Inc.
1 Jun 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-2.1
PFE
Pfizer Inc.
1 Jun 20
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-2.1
89prcezlrs
29 Jul 19
Entry into a Material Definitive Agreement
8:32am
8-K
EX-2.2
al75kxeda45of
29 Jul 19
Entry into a Material Definitive Agreement
8:32am
425
EX-2.1
icjopn4cgdqsmln 1c5
29 Jul 19
Business combination disclosure
8:30am
425
EX-2.2
89sj1w6tnly4yxh7gm0
29 Jul 19
Business combination disclosure
8:30am
8-K
EX-2.1
jlaeafe490u 9tf
22 Aug 16
Pfizer To Acquire Medivation
12:00am
SC TO-C
EX-2.1
qpb3y9pdk0el
22 Aug 16
Information about tender offer
12:00am
425
EX-2.1
qbi14ynfvk4ghdzrszvo
24 Nov 15
Business combination disclosure
12:00am
8-K
EX-2.1
ldp10
23 Nov 15
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
v2e 2j6d66s0
23 Nov 15
Business combination disclosure
12:00am
8-K
EX-2.1
fny15j
6 Feb 15
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
hvqxyr791k6jrzqyfq
29 Jan 09
Business combination disclosure
12:00am
8-K
EX-2.1
jcvcdm8w6gb6krkm9q
29 Jan 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
y6ilob
16 Jul 02
Other events
12:00am